At Robeauté we are developing a really small microrobot for novel therapies in hard-to-reach areas of the body. Designed specifically for the brain, at the service of neurosurgeons, our microrobot will be able to freely navigate in other complex regions of the body to perform biopsies, collect precise anatomically localized data and deliver therapies on site, at the right dosage. We are accompanying a major shift from robotic surgery to microrobotic surgery, for greater precision, better results and bold new therapies to tackle global diseases affecting more than a billion people worldwide. Our microrobot will light a spark in the minds of medical practitioners and scientists around the world, allowing them to imagine and create more effective treatments, to be delivered locally. We are a pluridisciplinary and multicultural team of passionate, skilled, supportive and creative people, at the crossroads of microrobotics, engineering and medicine. We work with phenomenal medical centers and university labs in Europe and the United States. Our team is growing and we are constantly on the lookout for highly-talented individuals. Working with us means working on something that has never been done before, so you will be challenged - and you will be supported. We are team players, with both classical and atypical backgrounds, so unconventional thinking is welcome and good communication skills are a must. We are based in Paris, France. Check out our website to see if there is a job opening for you. Follow us here as we tell you more of what we do.
Location: France
Employees: 1-10
Total raised: $28M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Urania Ven... | urania.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.01.2025 | - | $28M | - |
Mentions in press and media 6
| Date | Title | Description |
| 02.01.2026 | Robeauté is turning microrobotics into a surgical platform for the brain | There are around 350,000 people diagnosed with primary brain cancer every year, and 250,000 people die from it. Despite decades of progress in medicine, the tools primarily used to access, diagnose, and treat the brain remain limited — unti... |
| 15.01.2025 | Robeauté: Pioneering the Future of Neurosurgery with Microrobots | In the world of medicine, the brain is the final frontier. It holds the secrets to our thoughts, memories, and identities. Yet, when it comes to treating neurological disorders, the tools we use are often blunt instruments. Enter Robeauté, ... |
| 14.01.2025 | Robeauté Raises $28M in Funding | Robeautè, a Paris, France-based medtech startup developing neurosurgical microrobots, raised $28M in funding. The round was led by Plural, Cherry Ventures and Kindred Ventures. Other investors included LocalGlobe, Think.Health, APEX Venture... |
| 14.01.2025 | Robeauté raises $28M for neurosurgical microrobots for neurology, medicine's final frontier | French robotic medtech Robeauté has raised $28 million funding for its neurosurgical microrobots. Neurological disorders are difficult to diagnose in the early stages when intervention can have the most impact. Modern neurosurgery still rel... |
| 14.01.2025 | “Size of a grain of rice”: Robeauté raises €27.2 million to transform neurosurgery with microrobots | Robeauté, a Paris-based medtech startup developing neurosurgical microrobots, has announced the completion of a €27.2 million funding round to advance their microbot tech, initiate human trials in 2026, and establish operations in the US as... |
| - | Robeaute | “Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.” |